Cannabis 292.85 F12.188 F12.288 F12.988
Opioid 292.85 F11.182 F11.282 F11.982
Sedative, hypnotic, or anxiolytic 292.85 F13.182 F13.282 F13.982
Amphetamine (or other 292.85 F15.182 F15.282 F15.982
Cocaine 292.85 F14.182 F14.282 F14.982
Tobacco 292.85 NA F17.208 NA
Other (or unknown) substance 292.85 F19.182 F19.282 F19.982 |CD-9-CM. The name of the substance/ medication-induced sleep disorder begins with the specific substance (e.g., cocaine, bupropion) that is presumed to be causing the sleep disturbance. The diagnostic code is selected from the table included in the criteria set, which is based on the drug class. For substances that do not fit into any of the classes (e.g., bupropion), the code for ”other substance” should be used; and in cases in which a sub- stance is judged to be an etiological factor but the specific class of substance is unknown, the category ”unknown substance” should be used.
The name of the disorder is followed by the specification of onset (i.e., onset during in- toxication, onset during discontinuation/withdrawal), followed by the subtype designa- tion (i.e., insomnia type, daytime sleepiness type, parasomnia type, mixed type). Unlike the recording procedures for ICD-IO-CM, which combine the substance-induced disorder and substance use disorder into a single code, for ICD-9-CM a separate diagnostic code is given for the substance use disorder. For example, in the case of insomnia occurring during withdrawal in a man with a severe lorazepam use disorder, the diagnosis is 292.85 lorazepam-induced sleep disorder, with onset during withdrawal, insomnia type. An ad- ditional diagnosis of 304.10 severe lorazepam use disorder is also given. When more than one substance is judged to play a significant role in the development of the sleep distur- bance, each should be listed separately (e.g., 292.85 alcohol-induced sleep disorder, With onset during intoxication, insomnia type; 292.85 cocaine—induced sleep disorder, with on- set during intoxication, insomnia type).
|CD-1 O-CM. The name of the substance/medication-induced sleep disorder begins with the specific substance (e.g., cocaine, bupropion) that is presumed to be causing the sleep distur- bance. The diagnostic code is selected from the table included in the criteria set, which is based on the drug class and presence or absence of a comorbid substance use disorder. For sub- stances that do not fit into any of the classes (e.g., bupropion), the code for ”other substance” should be used; and in cases in which a substance is judged to be an etiological factor but the specific class of substance is unknown, the category "unknown substance" should be used.